Products
-
- 3D BBB Models
- Organ-on-a-Chip BBB ModelsTranswell Models3D BBB Models Culture Substrate
- 3D HydrogelsCollagensAnmial BBB ModelsCell Lines for BBB Modeling
- Immortalized CellsPrimary CellsStem Cells
Rat Semaphorin 7a ELISA Kit (AC2921)
Cat.#: ASET-1510
Specifications
Description Rat Semaphorin 7a ELISA Kit allows for the in vitro quantitative determination of rat Semaphorin 7a concentrations in serum, plasma, tissue homogenates, and other biological fluids. The kit employs the sandwich enzyme immunoassay technique. Size 96T Sample Type Serum, plasma, tissue homogenates, and other biological fluids. Reactivity Rat Unit 1 kit Packaging Kit of pre-coated 96 well microplates (12 x 8 well strips) Detection Type Colorimetric Assay Type Quantitative Sensitivity 0.188 ng/ml Precision Intra-assay CV: < 8%
Inter-assay CV: < 10%Product Range 0.313-20 ng/mL Assay Time 4h 30m Storage Store the unopened kit at +4°C. Shipping Wet ice Citation Guidance If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. Related Products
Cat.# Name Assay Type Price ASET-1121 Human TBX1 ELISA Kit (AC2532) Quantitative inquiry ASET-1649 Rat Syndecan-1 ELISA Kit (AC3060) Quantitative inquiry ASET-1876 Human TNF Receptor II ELISA Kit (AC3287) Quantitative inquiry ASET-1559 Rat Kappa Opioid Receptor ELISA Kit (AC2970) Quantitative inquiry ASET-1814 Mouse Granulin ELISA Kit (AC3225) Quantitative inquiry ASET-2226 Human CNTF ELISA Kit (AC3637) Quantitative inquiry ASET-1914 Human Frizzled 9 ELISA Kit (AC3325) Quantitative inquiry ASET-2310 Human C1QB ELISA Kit (AC3721) Quantitative inquiry ASET-2517 Mouse GAPDH ELISA Kit (AC3928) Quantitative inquiry ASET-2199 Mouse Ghrelin ELISA Kit (AC3610) Quantitative inquiry All of our products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
Quick Links0Inquiry Basket